Weight Loss Revolution

Watch our Expert Webinar

Is Your Practice Prepared?

Learn how to navigate the Semaglutide Shortage and provide best-in-class care for your patients

Register to Watch and get a FREE Cholesterol Test

Exploring Obesity Management and
Cutting-Edge Strategies with and without Semaglutides / GLP-1

Join an engaging discussion on the intersection of Semaglutide (Wegovy, Ozempic) and obesity management. Explore topics such as the progressive nature of obesity, the impact of social determinants of health, GLP-1 shortages and alternatives, telehealth support for patients, multimodal care approaches, and the role for your practice.

Gain insights into comprehensive obesity management plans, including nutrition, prescriptions, exercise, behavior therapy, and biotech advancements.

Discover the links between obesity and fertility, menopause, mental health, and longevity. Don't miss out on this enlightening discussion that will equip you with strategies to design innovative digital health offerings and deliver effective obesity management.

Featured Speakers

CEO Of Innovative Health Diagnostics

David White

David is is a thoughtful, compassionate leader committed to accessible and dignified healthcare. Specializing in cost-effective testing solutions and comprehensive support, to enhance accessibility while reducing costs. By leveraging cutting-edge research and technology, IHDLab aims to raise awareness, promote inclusivity, and foster equity. With a strong dedication to accessible healthcare to those who need it most.

Chief Medical Officer at Measured

Jennifer Peña, MD, FACP

Dr. Pena is a board-certified internal medicine physician, Army veteran, with over 15 years of clinical experience and most recently specializing in digital and telehealth. Her career includes leadership roles such as Chief Clinical Officer at Vault Health and Chief Medical Officer at K Health and Nurx. She currently serves as a consultant for several digital health companies, and is acting Chief Medical Officer for the weight loss management company Measured.

VP of Clinical Affairs at Openloop

Mohit Joshipura MD

Dr. Joshipura is a board-certified Internal Medicine physician proficient in developing digital health solutions for startups and Fortune 500 companies alike. He has experience managing nationally distributed clinical teams and designing obesity management programs for a variety of companies, including consulting for leaders in the space such as WeightWatchers (WW).

Topics Covered

Discover Latest Breakthroughs: Uncover how leading drug maker Novo Nordisk is revolutionizing weight loss treatments with their reformulated diabetes drugs, Ozempic and Wegovy, and how competitors are responding.

Experience Non-Medicinal Innovation: Learn about the ground-breaking drug-free pill that mimics fullness in the stomach and has led to impressive weight loss results in clinical trials, potentially redefining the weight loss market.

Financial Impact of Obesity: Understand how the substantial cost of obesity is likely to influence future price negotiations for diabetes drugs, potentially paving the way for innovative, cost-effective solutions.